Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWLuliconazole is a broad spectrum imidazole that is active against various fungi, including Tinea, Candida, Trichophyton, Aspergillus, and Epidermophyton.1,2 It has MIC values of 2.5-20, 0.63-2.5, 31-250, and ≤0.31-0.63 ng/ml for T. mentagrophytes, T. rubrum, C. albicans, and A. fumigatus, respectively, in broth dilution assays. In vitro, luliconazole has a geometric mean MIC value of 2.35 ng/ml against A. terreus, a fungal species responsible for life-threatening invasive aspergillosis in immunocompromised and high-risk patients.3 It prevents mortality in rats with systemic A. fumigatus infections and in mice with systemic C. albicans infections.2 It is effective in eliminating tinea pedis in a guinea pig model when used topically at a concentration of 1% once per day for seven days.1 Topical formulations containing luliconazole have been used in the treatment of fungal infections.
WARNING This product is not for human or veterinary use.
1. In vitro and in vivo antidermatophyte activities of NND-
2. Efficacy of NND-
3. Luliconazole, an alternative antifungal agent against Aspergillus terreus. J. Mycol. Med. 27(3), 351-356 (2017).